Suppr超能文献

脉络膜发芽检测法:一种微血管生成的体外模型。

Choroid sprouting assay: an ex vivo model of microvascular angiogenesis.

机构信息

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2013 Jul 26;8(7):e69552. doi: 10.1371/journal.pone.0069552. Print 2013.

Abstract

Angiogenesis of the microvasculature is central to the etiology of many diseases including proliferative retinopathy, age-related macular degeneration and cancer. A mouse model of microvascular angiogenesis would be very valuable and enable access to a wide range of genetically manipulated tissues that closely approximate small blood vessel growth in vivo. Vascular endothelial cells cultured in vitro are widely used, however, isolating pure vascular murine endothelial cells is technically challenging. A microvascular mouse explant model that is robust, quantitative and can be reproduced without difficulty would overcome these limitations. Here we characterized and optimized for reproducibility an organotypic microvascular angiogenesis mouse and rat model from the choroid, a microvascular bed in the posterior of eye. The choroidal tissues from C57BL/6J and 129S6/SvEvTac mice and Sprague Dawley rats were isolated and incubated in Matrigel. Vascular sprouting was comparable between choroid samples obtained from different animals of the same genetic background. The sprouting area, normalized to controls, was highly reproducible between independent experiments. We developed a semi-automated macro in ImageJ software to allow for more efficient quantification of sprouting area. Isolated choroid explants responded to manipulation of the external environment while maintaining the local interactions of endothelial cells with neighboring cells, including pericytes and macrophages as evidenced by immunohistochemistry and fluorescence-activated cell sorting (FACS) analysis. This reproducible ex vivo angiogenesis assay can be used to evaluate angiogenic potential of pharmacologic compounds on microvessels and can take advantage of genetically manipulated mouse tissue for microvascular disease research.

摘要

微血管生成是许多疾病(包括增生性视网膜病变、年龄相关性黄斑变性和癌症)的发病机制的核心。建立一个微小血管生成的小鼠模型将非常有价值,使人们能够获得广泛的遗传操作组织,这些组织非常接近体内小血管的生长。体外培养的血管内皮细胞被广泛应用,然而,分离纯血管的小鼠内皮细胞在技术上具有挑战性。一个强大、定量且易于重现的微小血管鼠外植体模型将克服这些限制。在这里,我们对一种源自脉络膜的器官型微小血管生成的小鼠和大鼠模型进行了特征描述和重现性优化,脉络膜是眼睛后部的一个微小血管床。从 C57BL/6J 和 129S6/SvEvTac 小鼠和 Sprague Dawley 大鼠中分离脉络膜组织,并在 Matrigel 中孵育。来自不同遗传背景的相同动物的脉络膜样本之间,血管发芽情况相当。相对于对照,独立实验之间发芽面积的重现性非常高。我们开发了一种半自动化的 ImageJ 软件宏,以实现更高效的发芽面积定量。分离的脉络膜外植体对外界环境的操纵有反应,同时保持内皮细胞与邻近细胞(包括周细胞和巨噬细胞)的局部相互作用,如免疫组织化学和荧光激活细胞分选(FACS)分析所示。这种可重现的体外血管生成测定可用于评估药物化合物对微血管的血管生成潜力,并可利用遗传操作的小鼠组织进行微小血管疾病研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9239/3724908/a91f179909e3/pone.0069552.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验